Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapies for HER2+ Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07616427
What this trial is testing

Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer

Who this might be right for
HR+/HER2+ Early Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Large-scale testing (Phase 3)Looking for participantsNCT06058377
What this trial is testing

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8HER2-Negative Breast Carcinoma+1 more
National Cancer Institute (NCI) 3,680
Testing effectiveness (Phase 2)Ended earlyNCT01388647
What this trial is testing

Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer

Who this might be right for
HER-2 Positive Breast Cancer
Vector Oncology 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03900637
What this trial is testing

PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate

Who this might be right for
Breast Cancer
Seoul National University Hospital 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT07130643
What this trial is testing

Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer

Who this might be right for
HR+/HER2- Breast Cancer
Xinhong Wu, PhD 40
Large-scale testing (Phase 3)Study completedNCT00309556
What this trial is testing

Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer

Who this might be right for
Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 536
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07290166
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of Anti-HER2 Triple-targeted Drugs Combined With CDK4/6 Inhibitors in Neoadjuvant Therapy for ER-positive HER2-positive Breast Cancer Patients.

Who this might be right for
Breast Cancer
Fudan University 42
Very early researchActive Not RecruitingNCT02744053
What this trial is testing

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+1 more
M.D. Anderson Cancer Center 96
Not applicableLooking for participantsNCT05263570
What this trial is testing

The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.

Who this might be right for
Breast Cancer
Shengjing Hospital 200
Not applicableNot Yet RecruitingNCT07662252
What this trial is testing

Circulating Tumor DNA Dynamics to Optimize Neoadjuvant Therapy in HER2-Positive and Triple-Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer (TNBC)HER2 + Breast Cancer
Federico II University 186
Testing effectiveness (Phase 2)Ended earlyNCT01368263
What this trial is testing

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerStage II Breast Cancer+3 more
Washington University School of Medicine 8
Large-scale testing (Phase 3)UnknownNCT00486668
What this trial is testing

AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

Who this might be right for
Invasive Breast Cancer
NSABP Foundation Inc 529
Testing effectiveness (Phase 2)Study completedNCT00194779
What this trial is testing

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerHER2-positive Breast Cancer+6 more
University of Washington 50
Large-scale testing (Phase 3)Looking for participantsNCT06830889
What this trial is testing

BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy

Who this might be right for
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 1,450
Not applicableStudy completedNCT00555152
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ

Who this might be right for
Ductal Breast Carcinoma In SituHER2/Neu Positive
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07317778
What this trial is testing

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)HR Positive/HER2 Low Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 249
Testing effectiveness (Phase 2)UnknownNCT05430347
What this trial is testing

Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 80
Testing effectiveness (Phase 2)Ended earlyNCT02598310
What this trial is testing

Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor Negative NeoplasmHER-2 Positive Breast Cancer
Osaka Medical College 30
Testing effectiveness (Phase 2)Study completedNCT00723125
What this trial is testing

Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer

Who this might be right for
Breast Cancer
William Sikov MD 60
Testing effectiveness (Phase 2)Ended earlyNCT01194869
What this trial is testing

Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Emory University 25
Next Page